It's time to kill the patient COVID-19 tax

It's time to kill the patient COVID-19 tax
Illustration Credit: Greg Groesch/Washington Times

More than 30 million Americans are now unemployed. These folks need all the help our nation can offer. Yet, disturbingly, the Trump administration just finalized a rule that will dramatically spike pharmacy costs. 

The rule allows insurers to disregard manufacturer coupons when calculating patients’ out-of-pocket expenses. This will increase what patients must spend before their insurance kicks in, potentially making critical prescriptions too expensive to fill.

For many Americans, high out-of-pocket costs already drive many to skip needed medicines.

 
Sign Up for Our Email Newsletter

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients...  Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis...  Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo...  Read more

DRUGWONKS BLOG